• Lantern Pharma Launches ADC Program contractpharma
    January 05, 2021
    ​Lantern Pharma, a clinical-stage biopharma company using its RADR artificial intelligence platform to advance cancer drug development, is launching the development of its ADC (Antibody Drug Conjugate) program through an evaluation and potential ...
  • Lantern Pharma and Fox Chase Cancer Center Collaborate contractpharma
    September 23, 2020
    Focus on advancing the development of LP-184 in pancreatic cancer.
PharmaSources Customer Service